Name: UMIN ID:
Unique ID issued by UMIN | UMIN000002810 |
---|---|
Receipt number | R000003406 |
Scientific Title | The establishment of a reference standard value for lower-extremity strength in patients with type 2 diabetes to clinically evaluate both the degree of diabetic complications and the effectiveness of exercise therapy |
Date of disclosure of the study information | 2009/11/30 |
Last modified on | 2019/09/30 21:20:15 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2009/11/29 10:58:51 | ||
2 | Update | 2010/04/01 19:04:01 | Institutions |
|
3 | Update | 2010/04/01 19:06:13 | Recruitment status |
|
4 | Update | 2010/04/13 14:56:44 | Institutions |
|
5 | Update | 2010/06/02 09:15:39 | Institutions |
|
6 | Update | 2010/07/27 11:58:17 | Institutions |
|
7 | Update | 2010/09/09 10:23:44 | Institutions |
|
8 | Update | 2010/10/01 22:35:05 | Institutions |
|
9 | Update | 2010/10/06 10:42:53 | Institutions |
|
10 | Update | 2010/12/13 22:02:10 | Institutions |
|
11 | Update | 2010/12/23 12:28:47 | Institutions |
|
12 | Update | 2011/02/19 00:20:37 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
13 | Update | 2011/02/22 09:47:19 | Institutions |
|
14 | Update | 2011/02/26 00:12:05 | Institutions |
|
15 | Update | 2011/03/01 16:19:01 | Institutions |
|
16 | Update | 2011/03/26 09:26:54 | Institutions |
|
17 | Update | 2011/04/17 01:26:23 | Organization Organization Division name Division name Address Address TEL Organization Organization Division name Division name Address Address TEL Organization Organization Division name Division name Address Address TEL Institute Institute |
|
18 | Update | 2011/05/03 01:00:27 | Organization Organization Category of Funding Organization Nationality of Funding Organization Nationality of Funding Organization |
|
19 | Update | 2011/05/17 09:53:25 | Institutions |
|
20 | Update | 2011/06/15 10:54:18 | Organization1 Address1 Tel1 Email1 |
|
21 | Update | 2011/06/22 03:02:32 | Institutions |
|
22 | Update | 2011/07/07 16:03:29 | Post marketing survey by drug manufacture etc., specified by Japanese law. Institutions |
|
23 | Update | 2011/07/20 15:23:52 | Institutions |
|
24 | Update | 2011/12/14 14:16:35 | Email1 |
|
25 | Update | 2012/06/19 19:36:40 | Institutions |
|
26 | Update | 2012/07/12 22:03:04 | Institutions |
|
27 | Update | 2012/07/24 14:04:57 | Institutions |
|
28 | Update | 2012/10/03 20:18:15 | Institutions |
|
29 | Update | 2012/12/26 16:06:12 | Institutions |
|
30 | Update | 2013/04/15 14:12:45 | Institutions |
|
31 | Update | 2013/11/10 15:09:40 | Email Organization Organization Institutions |
|
32 | Update | 2013/11/28 18:32:06 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
33 | Update | 2014/05/30 07:48:48 | Institutions |
|
34 | Update | 2014/06/17 10:46:14 | Publication of results URL related to results and publications |
|
35 | Update | 2014/10/17 09:39:03 | URL releasing protocol |
|
36 | Update | 2014/10/17 09:42:24 | Other related information Other related information |
|
37 | Update | 2015/05/31 20:42:36 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
38 | Update | 2015/11/05 16:24:02 | Results Results |
|
39 | Update | 2017/03/20 21:16:45 | Email Name of primary person or sponsor Institute Organization Organization Category of Funding Organization Email1 |
|
40 | Update | 2017/03/20 21:18:53 | Publication of results Other related information Other related information |
|
41 | Update | 2017/07/19 09:47:24 | Other related information Other related information |
|
42 | Update | 2018/03/25 13:19:39 | Other related information Other related information |
|
43 | Update | 2019/01/16 10:45:31 | Results Results Other related information Other related information |
|
44 | Update | 2019/09/30 20:50:07 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Last name of contact person Last name of contact person Zip code Address Address Organization1 Organization Organization Address Address Tel |
|
45 | Update | 2019/09/30 21:14:00 | Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
46 | Update | 2019/09/30 21:20:15 | Date of IRB |